Arslanhan Gökhan, Özcan Zeynep Sıla, Şenay Şahin, Baştopçu Murat, Karaağaç Anıl, Koçyiğit Muharrem, Değirmencioğlu Aleks, Alis Deniz, Alhan Cem
Department of Cardiovascular Surgery, Acibadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Turkey.
Department of Anesthesiology, Acibadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Turkey.
Int J Med Robot. 2025 Jun;21(3):e70071. doi: 10.1002/rcs.70071.
Robotic assistance has many advantages in minimally invasive coronary bypass surgery, such as the harvest of a longer portion of the LIMA in addition to the avoidance of sternotomy, thus offering a less invasive approach for multivessel revascularisation. We present the midterm clinical outcomes of robotic-assisted minimally invasive coronary bypass (RA-CABG) cases at our centre.
One hundred and fifty consecutive patients who underwent RA-CABG with preoperative computed tomography angiography guidance were studied. Robotic LIMA harvesting was performed. The main outcome measure of the study was the midterm survival and incidence of major adverse cardiovascular events (MACE) up to 5 years.
The median follow-up was 19.8 months. In the Kaplan-Meier survival analysis, 1-year survival was 99.1% and 5-year survival was 97.5%. 1-year freedom from MACE was 97.3% and 5-year freedom from MACE was 95%.
Robotic-assisted minimally invasive coronary bypass surgery has safe midterm outcomes and can be performed with excellent results.
机器人辅助在微创冠状动脉搭桥手术中具有诸多优势，例如能够获取更长的左乳内动脉，同时避免开胸，从而为多支血管血运重建提供了一种侵入性较小的方法。我们展示了本中心机器人辅助微创冠状动脉搭桥术（RA-CABG）病例的中期临床结果。
对150例在术前计算机断层扫描血管造影引导下接受RA-CABG的连续患者进行研究。进行了机器人辅助的左乳内动脉采集。该研究的主要结局指标是长达5年的中期生存率和主要不良心血管事件（MACE）的发生率。
中位随访时间为19.8个月。在Kaplan-Meier生存分析中，1年生存率为99.1%，5年生存率为97.5%。1年无MACE生存率为97.3%，5年无MACE生存率为95%。
机器人辅助微创冠状动脉搭桥手术具有安全的中期结果，并且可以取得优异的效果。
